Lack of significant variability among different methods for calculating antimicrobial days of therapy

Infection Control and Hospital Epidemiology

Volumn 33, Issue 4, 2012, Pages 421-423

  Kubin, Christine J ^a   Jia, Haomiao ^b   Alba, Luis R ^a   Yoko Furuya, E ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BINOMIAL DISTRIBUTION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; ORGAN TRANSPLANTATION; TREATMENT DURATION;

ADULT; ANTI-INFECTIVE AGENTS; CEFTRIAXONE; DRUG DOSAGE CALCULATIONS; HUMANS; KIDNEY DISEASES; OFLOXACIN; PENICILLANIC ACID; PIPERACILLIN; TIME FACTORS; TOBRAMYCIN; VANCOMYCIN;

EID: 84858807956     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/664770     Document Type: Article

References (5)

1. Shlaes DM, Gerding DN, John JF Jr, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997;18(4):275-291.
2. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44(2): 159-177.
3. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007;44(5):664-670.
4. Division of Infectious Diseases. Clinical references. Columbia University Medical Center Division of Infectious Diseases Web site. http://www.cumc.columbia.edu/dept/id/clinical_references.html. Published June 2011. Accessed December 12, 2011.
5. Zagorski BM, Trick WE, Schwartz DN, et al. The effect of renal dysfunction on antimicrobial use measurements. Clin Infect Dis 2002;35:491-497.